*The following content is generated by AI and is for reference only.
Overview
1-[(4-methylquinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-bromoxanthine is a specialized xanthine derivative synthesized via alkylation and coupling reactions. It serves as a high-purity intermediate for pharmaceutical research, with molecular formula C22H21BrN6O2. CAS number verification required for specific batches.
Application
- Pharmaceutical R&D: Precursor for developing novel adenosine receptor antagonists.
- Medicinal Chemistry: Used in structure-activity relationship (SAR) studies targeting CNS disorders.
- Biochemical Assays: Applied in enzyme inhibition profiling for kinase activity screening.
Precautions
Strictly for laboratory use only; not approved for clinical therapy. Store under inert atmosphere at -20°C to prevent hydrolysis. Handle with appropriate PPE due to potential mutagenicity and environmental hazards.